Temporal (Circadian) and Functional Relationship Between Atrial Natriuretic Peptides and Blood Pressure
- 1 January 1995
- journal article
- research article
- Published by Taylor & Francis in Chronobiology International
- Vol. 12 (2) , 106-120
- https://doi.org/10.3109/07420529509064506
Abstract
Long-acting natriuretic peptide, vessel dilator, and atrial natriuretic factor consisting of amino acids (a.a.) 1 to 30, 31 to 67, and 99 to 126 of the 126-a.a. atrial natriuretic factor (ANF) prohormone, respectively, circulate in humans and have potent vasodilatory properties. To determine if these atrial natriuretic peptides are directly related to blood pressure in clinically healthy normotensive humans, we obtained 24-h profiles of vessel dilator, long-acting natriuretic peptide, ANF, and blood pressure in 10 men in 1988 and 11 men in 1993 (seven men were studied twice) to compare circulating concentrations of atrial natriuretic peptides with naturally occurring changes in blood pressure. Overall, vessel dilator, long-acting natriuretic peptide, and ANF each had significant (p<0.001) circadian rhythms, with peak concentrations late during sleep (at 04:00 h) being nearly twice their concentrations in the afternoon and evening. This high-amplitude circadian change allowed for the refinement of normal limits for ANF peptides by computing 3-hourly tolerance intervals (chronodesms) against which to compare time-specified single samples for normality. Systolic, diastolic, and mean arterial blood pressure also had significant circadian rhythms (p<0.001) with peaks and troughs that were exactly opposite those of the ANF peptides. In addition to this inverse temporal relationship, there was a significant inverse correlation between absolute values for blood pressure and each ANF peptide (p<0.001), implying a functional relationship. These data suggest that in addition to other well-established neurochemical factors, the ANF peptides (vessel dilator, long-acting natriuretic peptide, and ANF) are important for the maintenance of blood pressure and modulation of its circadian rhythm.Keywords
This publication has 23 references indexed in Scilit:
- Three peptides from the atrial natriuretic factor prohormone amino terminus lower blood pressure and produce diuresis, natriuresis, and/or kaliuresis in humans.Circulation, 1994
- The N-terminal and C-terminal portions of the atrial natriuretic factor prohormone increase during preeclampsiaAmerican Journal of Obstetrics and Gynecology, 1991
- Increased Circulating Concentration of the N-Terminus of the Atrial Natriuretic Factor Prohormone in Persons with Pheochromocytomas*Journal of Clinical Endocrinology & Metabolism, 1990
- Weight reduction decreases atrial natriuretic factor and blood pressure in obese patientsMetabolism, 1989
- Atrial natriuretic prohormone peptides 1–30, 31–67, and 79–98 vasodilate the aortaBiochemical and Biophysical Research Communications, 1987
- Obituary Notice Robert C. TaraziJournal Of Hypertension, 1986
- RAISED CIRCULATING LEVELS OF ATRIAL NATRIURETIC PEPTIDES IN ESSENTIAL HYPERTENSIONThe Lancet, 1986
- PLASMA CONCENTRATION OF ATRIAL NATRIURETIC POLYPEPTIDE IN ESSENTIAL HYPERTENSIONThe Lancet, 1985
- Bioactive Cardiac Substances: Potent Vasorelaxant Activity in Mammalian AtriaScience, 1983
- A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in ratsLife Sciences, 1981